10 Jim Cramer Stocks to Watch This Month
"They wipe out these gains pretty easily, don't they? Just like that, the sellers take away months, if not years, of profits because they want to get ahead of a potential recession.
Adma Biologics Inc. (ADMA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 3,769,888 | $64,653,579 | +3% | 0.09% |
| 2. | D E Shaw D. E. Shaw | 3,066,575 | $52,591,762 | -42% | 0.03% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 2,950,124 | $50,594,627 | -34% | 0.11% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 2,762,700 | $47,380,305 | +58% | 0.03% |
| 5. | Altium Capital Jacob Gottlieb | 1,395,000 | $23,924,250 | +3% | 6.78% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.71 | 130,000 | 443,265 | 2023-08-30 | Filing | ||
| $3.90 | 25,000 | 277,401 | 2023-08-24 | Filing | ||
| $2.86 | 6,993 | 1,034,825 | 2022-12-09 | Filing | ||
| $2.86 | 14,982 | 1,143,426 | 2022-12-09 | Filing | ||
| $2.86 | 14,983 | 2,203,708 | 2022-12-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.92 | 6,000 | 2,061,850 | 2025-03-19 | Filing | ||
| $18.92 | 15,000 | 2,067,850 | 2025-03-19 | Filing | ||
| $21.15 | 15,000 | 199,433 | 2024-11-22 | Filing | ||
| $21.10 | 48,967 | 1,989,007 | 2024-11-22 | Filing | ||
| $18.47 | 9,000 | 153,941 | 2024-09-09 | Filing |
Institutional Investors' Holdings
News See All
ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to the ADMA Biologics Fourth Quarter and Full Year 2024 Financial Results and Business Update Conference Call on Monday, March 3rd, 2025.
8 Stocks on Jim Cramer's Radar
Jim Cramer, host of Mad Money, recently discussed some of the significant challenges the alcohol industry is facing.
15 Best Growth Stocks to Buy for the Next 5 Years
Kevin Mahn, President & CIO at Hennion & Walsh Asset Management, recently appeared on CNBC on January 6 to discuss the current market momentum and emphasize the need for investors to be selective in 2025...
12 Best Growth Stocks Under $25 to Buy Now
Most experts agree that the AI wave is not over yet.
12 Best Multibagger Stocks to Buy Right Now
The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs.
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Celine and I will be your conference operator today.
10 Best Performing Small-Cap Stocks in 2024
The recent Fed rate cut has made the market cautiously optimistic. Despite the unusual timing, historical data suggests a continued upward trend. Recently, we discussed the Dow's new all-time high.
ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the ADMA Biologics Second Quarter 2024 Financial Results and Business Update Conference Call on Thursday, August 08, 2024.
ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript
ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.07532, expectations were $0.05.